Attovia Therapeutics

Biotech · Public

Anti-IL-31RA monoclonal antibody biologic therapeutic for atopic dermatitis and pruritic diseases

attoviatx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
19
2 granted · 17 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3345Enara Bio——
3346FLASHPOINT THE ACADEMY OF MEDIA ARTS & SCIENCES LLC—$1.0M
3347MAVERIX BIOMICS, INC.—$8.0M
3348Attovia Therapeutics——
3349CETYA THERAPEUTICS, INC.——
3350Aethl Bio, Inc.—$1.6M
3351PRIMORDIAL GENETICS, INC.—$1.6M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Press

2 articles · matched on company name

Patents

USPTO · 2 granted of 19
  • IL31-BINDING Polypeptides And Uses Thereofapplication
  • IL13 And IL31 Bispecific Polypeptides And Uses Thereofgranted
  • IL31-BINDING Polypeptides And Uses Thereofgranted
  • IL13-BINDING Polypeptides And Uses Thereofapplication
  • IL13 And IL31 Bispecific Polypeptides And Uses Thereofapplication
  • IL13-BINDING Polypeptides And Uses Thereofapplication
  • IL13-BINDING Polypeptides And Uses Thereofapplication
  • IL13-BINDING Polypeptides And Uses Thereofapplication
  • IL13 And IL31 Bispecific Polypeptides And Uses Thereofapplication
  • IL13-BINDING And IL31-BINDING Polypeptides And Uses Thereofapplication
  • IL31-BINDING Polypeptides And Uses Thereofapplication
  • IL31-BINDING Polypeptides And Uses Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.